These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14826388)

  • 1. [Lakomalt; distribution].
    Medika (Zagreb); 1951 Feb; 4(2):22. PubMed ID: 14826388
    [No Abstract]   [Full Text] [Related]  

  • 2. [National health legislations. Dispensing drugs to persons covered by national health insurance].
    Zdrav Rev Vestn Minist Zdrav; 1950 Nov; 25(11):297. PubMed ID: 14810050
    [No Abstract]   [Full Text] [Related]  

  • 3. Royal commission on social security.
    N Z Med J; 1970 Jan; 71(452):36-43. PubMed ID: 5265870
    [No Abstract]   [Full Text] [Related]  

  • 4. [The national health insurance system for employees and the National Drug Formulary (N.D.F.) (author's transl)].
    Valdivieso R
    Rev Med Chil; 1977 Oct; 105(10):663-7. PubMed ID: 398055
    [No Abstract]   [Full Text] [Related]  

  • 5. [Harmful effects of drugs. Liability of the manufacturers against insurance claims for damages].
    Dahl B
    Ugeskr Laeger; 1984 Sep; 146(36):2726-8. PubMed ID: 6515894
    [No Abstract]   [Full Text] [Related]  

  • 6. [Obligation of the health-insurance physician to follow drug guide-lines].
    Rieger HJ
    Dtsch Med Wochenschr; 1975 Jan; 100(4):158-61. PubMed ID: 1112222
    [No Abstract]   [Full Text] [Related]  

  • 7. [Federal legislation in the field of health, social, tax, and economy policies].
    Mandt P
    Zahnarztl Mitt; 1972 Oct; 62(19):971-2 passim. PubMed ID: 4507221
    [No Abstract]   [Full Text] [Related]  

  • 8. [Schröder intervenes in drug savings package. Sparing for the industry, more restrictions for us physicians?].
    Jentsch P
    MMW Fortschr Med; 2001 Nov; 143(44):50-1. PubMed ID: 11732397
    [No Abstract]   [Full Text] [Related]  

  • 9. [EC-legislation and health care; various relevant aspects].
    Roscam Abbing HD
    Ned Tijdschr Geneeskd; 1990 Mar; 134(11):544-8. PubMed ID: 2320148
    [No Abstract]   [Full Text] [Related]  

  • 10. [Medical legislation in the 1972 literature].
    Schulz G
    Med Klin; 1973 Aug; 68(34):1124-31. PubMed ID: 4598150
    [No Abstract]   [Full Text] [Related]  

  • 11. A full plate.
    Nolen RS
    J Am Vet Med Assoc; 2003 Feb; 222(3):271-2. PubMed ID: 12564580
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug manufacturer on the savings package of Ulla Schmidt. "Grip in the moth box of planned economics"].
    Schmidt K
    MMW Fortschr Med; 2001 Nov; 143(44):52. PubMed ID: 11732398
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of health care in the United States.
    Isbister JD; McGaw N
    J Health Hum Resour Adm; 1978 Aug; 1(1):11-29. PubMed ID: 10297245
    [No Abstract]   [Full Text] [Related]  

  • 14. Economic consequences of the maximum allowable cost program to the entire profession of pharmacy.
    Paul SH
    Med Mark Media; 1979 Aug; 14(8):19-26. PubMed ID: 10243270
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of the West German drug law upon development of clinical pharmacology.
    Kampffmeyer H
    Clin Pharmacol Ther; 1974 Sep; 16(3):616-9. PubMed ID: 4413783
    [No Abstract]   [Full Text] [Related]  

  • 16. US Medicare reform: why drug companies and private insurers are smiling.
    Hurley J; Morgan S
    CMAJ; 2004 Feb; 170(4):461-2. PubMed ID: 14970088
    [No Abstract]   [Full Text] [Related]  

  • 17. [The physician and medical expert law].
    Friederichs H
    Fortschr Med; 1978 Oct; 96(38):1937-8. PubMed ID: 700581
    [No Abstract]   [Full Text] [Related]  

  • 18. [The clausulation for gabapentin and pregabalin was not used in accordance to the rules].
    Bjarnason NH; Laursen N
    Ugeskr Laeger; 2006 Feb; 168(8):811; author reply 811-2. PubMed ID: 16499858
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug effectiveness in the framework of drug legislation and health insurance law].
    Töns H
    Internist (Berl); 1980 Jun; 21(6):339-45. PubMed ID: 7005171
    [No Abstract]   [Full Text] [Related]  

  • 20. MAG's pro-active, pro-patient legislative agenda: key to unparalleled success.
    Cook D
    J Med Assoc Ga; 1999 Sep; 88(3):12-8. PubMed ID: 10544556
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.